The Latest Breaking News from diabetes

TikTokers are using the dietary supplement berberine, calling it "nature's Ozempic" as a weight-loss drug that's cheaper and easier to attain.

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

The stereotypical cannabis connoisseur perpetually has the munchies but is, paradoxically, perplexingly thin. Now researchers at the University of California, Irvine, think they know why—and no, pot consumption isn’t the secret to a svelte figure. Not a healthy one, anyway.

Being an early riser is associated with improved mental health and life satisfaction and a decreased risk of diabetes and obesity.

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

Researchers found that those with type two diabetes are more at risk of undiagnosed heart disease which could lead to heart attack and stroke.

In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how health care providers – and the public – view weight loss.

Type 1 diabetes affects 46.3 million individuals globally, with an annual rise of roughly 3 per cent. Read further on Dynamite News:

Developing diabetes before the age of 60 triples your risk of develeoping dementia later on, according to a new study.